butenafine, 101828-21-1

Articles:

PubMed:	Diagnosis and management of tinea infections.
PubMed:	Ruthenium-catalyzed reductive methylation of imines using carbon dioxide and molecular hydrogen.
PubMed:	Tinea nigra presenting speckled or "salt and pepper" pattern.
PubMed:	HPLC-DAD for the determination of three different classes of antifungals: method characterization, statistical approach, and application to a permeation study.
PubMed:	A case of Tinea nigra associated to a bite from a European rabbit (Oryctolagus cuniculus, Leporidae): the role of dermoscopy in diagnosis.
PubMed:	Fungal toenail infections.
PubMed:	Antimycotics suppress the Malassezia extract-induced production of CXC chemokine ligand 10 in human keratinocytes.
PubMed:	A comparative study to evaluate efficacy, safety and cost-effectiveness between Whitfield's ointment + oral fluconazole versus topical 1% butenafine in tinea infections of skin.
PubMed:	A comparative randomized open label study to evaluate efficacy, safety and cost effectiveness between topical 2% sertaconazole and topical 1% butenafine in tinea infections of skin.
PubMed:	In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
PubMed:	Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
PubMed:	Chiral N-benzyl-N-methyl-1-(naphthalen-1-yl)ethanamines and their in vitro antifungal activity against Cryptococcus neoformans, Trichophyton mentagrophytes and Trichophyton rubrum.
PubMed:	Influence of penetration enhancers and molecular weight in antifungals permeation through bovine hoof membranes and prediction of efficacy in human nails.
PubMed:	Suppressive effects of antimycotics on thymic stromal lymphopoietin production in human keratinocytes.
PubMed:	Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments.
PubMed:	Comparison of superficial mycosis treatment using Butenafine and Bifonazole nitrate clinical efficacy.
PubMed:	Tinea nigra: successful treatment with topical butenafine.
PubMed:	Squalene monooxygenase - a target for hypercholesterolemic therapy.
PubMed:	Determination of butenafine hydrochloride in human plasma by liquid chromatography electrospray ionization-mass spectrometry following its topical administration in human subjects.
PubMed:	Fungal toenail infections.
PubMed:	Stability-indicating LC assay for butenafine hydrochloride in creams using an experimental design for robustness evaluation and photodegradation kinetics study.
PubMed:	RP-HPLC method for simultaneous determination of butenafine hydrochloride and betamethasone dipropionate in a cream formulation.
PubMed:	A simple and rapid method to assess butenafine hydrochloride in skin samples and a comparative cutaneous retention study of two marketed formulations.
PubMed:	Studies on comparison of the efficacy of terbinafine 1% cream and butenafine 1% cream for the treatment of Tinea cruris.
PubMed:	Simultaneous HPLC determination of butenafine hydrochloride and betamethasone in a cream formulation.
PubMed:	[Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
PubMed:	In vitro antifungal activities of luliconazole, a new topical imidazole.
PubMed:	Are placebo-controlled trials of creams for athlete's foot still justified?
PubMed:	Butenafine and superficial mycoses: current status.
PubMed:	Fungal toenail infections.
PubMed:	Randomised controlled trial of topical butenafine in tinea cruris and tinea corporis.
PubMed:	Topical treatments for fungal infections of the skin and nails of the foot.
PubMed:	In vitro activities of miltefosine and two novel antifungal biscationic salts against a panel of 77 dermatophytes.
PubMed:	An unprecedented rearrangement in collision-induced mass spectrometric fragmentation of protonated benzylamines.
PubMed:	[The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
PubMed:	What is the best way to treat tinea cruris?
PubMed:	Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial.
PubMed:	In vitro antifungal activity of ZJ-522, a new triazole restructured from fluconazole and butenafine, against clinically important fungi in comparison with fluconazole and butenafine.
PubMed:	Topical therapy for fungal infections.
PubMed:	Role of antifungal agents in the treatment of seborrheic dermatitis.
PubMed:	Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria.
PubMed:	Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.
PubMed:	Butenafine: an update of its use in superficial mycoses.
PubMed:	KP-103, a novel triazole derivative, is effective in preventing relapse and successfully treating experimental interdigital tinea pedis and tinea corporis in guinea pigs.
PubMed:	A Japanese case of tinea corporis caused by Arthroderma benhamiae.
PubMed:	Six novel antimycotics.
PubMed:	Butenafine hydrochloride (Mentax) cream for the treatment of hyperkeratotic type tinea pedis and its transfer into the horny layer, with or without concomitant application of 20% urea ointment (Keratinamin).
PubMed:	Experimental and conformational analyses of interactions between butenafine and lipids.
PubMed:	Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis).
PubMed:	Comparison of in vitro antifungal activities of topical antimycotics launched in 1990s in Japan.
PubMed:	In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.
PubMed:	Butenafine hydrochloride: for the treatment of interdigital tinea pedis.
PubMed:	Azole antifungal agents related to naftifine and butenafine.
PubMed:	Contact dermatitis due to tea tree oil.
PubMed:	The antifungal agent butenafine manifests anti-inflammatory activity in vivo.
PubMed:	Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream.
PubMed:	Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study.
PubMed:	Allylamine type xanthone antimycotics.
PubMed:	Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis.
PubMed:	An overview of topical antifungal therapy in dermatomycoses. A North American perspective.
PubMed:	Butenafine.
PubMed:	A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent.
PubMed:	Topical butenafine for tinea pedis.
PubMed:	Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial.
PubMed:	One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
PubMed:	Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream.
PubMed:	Update on topical therapy for superficial fungal infections: focus on butenafine.
PubMed:	Neutral red assay in minimum fungicidal concentrations of antifungal agents.
PubMed:	Thiophene congeners of morpholine and allylamine type antifungals--syntheses and biological activities.
PubMed:	[A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis].
PubMed:	Two mechanisms of butenafine action in Candida albicans.
PubMed:	Anti-Trichophyton mentagrophytes activity and percutaneous permeation of butenafine in guinea pigs.
PubMed:	Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs.
PubMed:	[Antifungal agents--recent trends in development and progress in research of action mechanism].
PubMed:	[Synthesis and antifungal activity of butenafine hydrochloride (KP-363), a new benzylamine antifungal agent].
PubMed:	Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs.
PubMed:	Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs.